Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod

NCT05516303 · clinicaltrials.gov ↗

UNKNOWN

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

GENETIC: Genetic polymorphism
DIAGNOSTIC_TEST: Measurement of fingolimod and fingolimod-phosphate concentrations

Sponsor

University Hospital, Caen